Ponoi Capital II, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 24,480 shares at $13.78 ($337K) on 2019-06-24, disclosed to the SEC on 2019-06-26.
Open-market purchase of $337k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.78 | 12,240 | $169K | 50.0% |
| 2 | $13.78 | 12,240 | $169K | 50.0% |
| Total | $13.78 avg | 24,480 | $337K | 100% |
| Filing → |
| NGM | BUY | 2022-10-27 | $1.2M | — | Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |
| RAPT | SELL | 2021-09-29 | $578K | — | Filing → |